Aarti Pharmalabs formally inaugurates R&D Laboratory in Nerul

19 Dec 2023 Evaluate

Aarti Pharmalabs has formally inaugurated its new Research and Development (‘R&D’) Laboratory in Nerul, which has now become fully operationalised. This cutting-edge facility symbolizes the Company's commitment to advancing research and development in the pharmaceutical sector.

The company’s new R&D center is poised to enhance its Contract Development & Manufacturing (CDMO) business. The laboratory has cutting-edge technology based equipment and instruments including a section dedicated for flow chemistry. Focused on prioritizing safety and sustainability, the facility houses a Process Safety Laboratory equipped with advanced technology that meticulously studies both intended and unintended reactions, ensuring the highest standards of safety. 

The dedicated powder safety section further underscores APL's unwavering commitment to meticulous risk management. The facility boasts the latest designs of fume hoods, along with a state-of-the-art HVAC and Scrubbing system, to safeguard scientists and ensure a secure working environment. Embracing environmental consciousness, the laboratory is entirely paperless, utilizing e-books and the latest software to conduct experiments. This eco-friendly approach marks a significant step towards sustainability.

Aarti Pharmalabs (APL) (Formerly known as Aarti Organics) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint. 


Aarti Pharmalabs Share Price

511.15 0.70 (0.14%)
07-May-2024 14:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1513.65
Dr. Reddys Lab 6216.05
Cipla 1383.15
Zydus Lifesciences 983.55
Lupin 1589.35
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.